ModuAller
ModuAller, licence 80042563: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- RX BALANCE TECHNOLOGY INC.
- NPN or DIN-HM
- 80042563
- Status
- Active licence
- Licence date
- 30 May 2013
- Revision date
- 19 July 2013
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bêta-sitostérol-bêta-D-glycoside Source : Sitogluside | 0.134 mg | Not calculated |
| Urtica dioica Source : Sommité Extraction ratio : 20.0:1.0 Dry plant equivalent : 500.0 mg | 25.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Dioxyde de silicium, Cellulose microcristalline, Stéarate de magnésium, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Antioxidant. Used in Herbal Medicine as supportive therapy to help relieve rheumatic complaints. Used in Herbal Medicine as a nutritive tonic. Used in Herbal Medicine to help relieve seasonal allergy symptoms. (Feverfew is traditionally) used in Herbal Medicine to aid digestion. Feverfew is traditionally used in Herbal Medicine to help relieve headaches. Helps to support a healthy immune system balance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking blood thinners. Should not be used in organ and tissue transplant recipients, including bone marrow and corneal transplants, individuals with a history of diabetes or multiple sclerosis, unless on the advice or and under the direct supervision of a health care practitioner.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Do not use if you have sitosterolemia.
Source
Official Health Canada record, licence 80042563
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.